| Discontinuing omalizumab treatment in super-responder patients with allergic severe asthma: can the baseline total IgE level be used as a biological marker to decide … B Arslan, G Paçacı Çetin, M Türk, İ Gülmez, İ Yılmaz International Archives of Allergy and Immunology 183 (10), 1071-1077, 2022 | 14 | 2022 |
| Effectiveness of mepolizumab therapy on symptoms, asthma exacerbations, steroiddependence, and small airways in patients with severe eosinophilic asthma I Yilmaz, SN Bahçecioğlu, M Türk, N Tutar, GP ÇETİN, B Arslan Turkish journal of medical sciences 51 (4), 1953-1959, 2021 | 7 | 2021 |
| Picturing asthma in Turkey: results from the Turkish adult asthma registry GE Celik, O Aydin, D Gokmen, G Koycu Buhari, Z Celebi Sozener, ... Journal of Asthma 60 (11), 1973-1986, 2023 | 4 | 2023 |
| Anti-IL5/IL5R switching between biologics in patients with severe eosinophilic asthma İ Yılmaz, GP Çetin, B Arslan The Journal of Allergy and Clinical Immunology: In Practice 10 (7), 1935-1936, 2022 | 3 | 2022 |
| Biologics for the treatment of severe asthma: Current status report 2023 GP Çetin, SK Özdemir, ÖC Bostan, N Öztop, ZÇ Sözener, G Karakaya, ... Tuberculosis and Thorax 71 (2), 2023 | 2 | 2023 |
| The adequacy of current diagnostic criteria for making a diagnosis of ABPA ABPA tanısında güncel tanısal kriterler yeterli midir? S Nazik Bahçecioğlu, M Türk, G PAÇACI ÇETİN, İ YILMAZ Tuberkuloz ve Toraks 70 (2), 2022 | 2 | 2022 |
| The Management of Acute and Chronic Urticaria İ YILMAZ, GP ÇETİN, B ARSLAN, M TÜRK Asthma Allergy Immunology 20 (3), 202-204, 2022 | 1 | 2022 |
| Mepolizumab-related adverse events in severe eosinophilic asthma: A real-life study SN BAHÇECİOĞLU, M Türk, E Atayık, GP Çetin, B Arslan, İ Gülmez Asthma Allergy Immunol 2022; 20: 81 6, 2022 | 1 | 2022 |
| Venom immunotherapy and difficulties encountered before and during immunotherapy: Double sensitization, systemic reactions, treatment with omalizumab, and high dose VIT GP ÇETİN, I Yilmaz, M Türk, B Arslan, SN Bahçecioğlu Turkish Journal of Medical Sciences 52 (4), 1223-1234, 2022 | 1 | 2022 |
| Long-term macrolide therapy in asthma B Arslan, İ Yılmaz Tuberkuloz ve Toraks 69 (4), 520-534, 2021 | 1 | 2021 |
| The visible and invisible faces of the iceberg of type 2 asthma İ Yılmaz, GP Çetin American Journal of Respiratory and Critical Care Medicine 203 (11), 1443-1444, 2021 | 1 | 2021 |
| The Effectiveness of Biological Agents on Chronic Rhinosinusitis with Nasal Polyposis in Patients with Comorbid Asthma: A Multicenter Real-Life Study from Türkiye M Demir, C Tunakan Dalgic, EN Mete Gokmen, R Savas, S Eroglu, ... Medicina 60 (3), 448, 2024 | | 2024 |
| Doxycycline may be more clinically effective in type 2 chronic rhinosinusitis nasal polyp comorbid with asthma G Paçacı Çetin, B Arslan, İ Yılmaz Journal of Asthma 61 (1), 20-26, 2024 | | 2024 |
| Immunizations and Antibiotic Prophylaxis in Patients with Primary Immunodeficiency Diseases GP ÇETİN, N ÖZTOP Turkiye Klinikleri Immunology Allergy-Special Topics 17 (1), 98-104, 2024 | | 2024 |
| The Role of Long-Acting Antimuscarinic Agents in the Treatment of Asthma B Arslan, GP Çetin, İ Yilmaz Journal of Aerosol Medicine and Pulmonary Drug Delivery 36 (4), 189-209, 2023 | | 2023 |
| Can clarithromycin be used without testing in patients with penicillin allergy? B Arslan, GP Çetin, İ Yılmaz Revue Française d'Allergologie 63 (4), 103615, 2023 | | 2023 |
| Should There be a Washout Period When Switching to Another Biological in Asthma? GP CETIN, HEB YILMAZ, I YILMAZ | | 2023 |
| Safety Profiles of Biological Therapies Used in Asthma Treatment. G PAÇACI ÇETIN, B ARSLAN, I YILMAZ Asthma Allergy Immunology/Astim Allerji Immunoloji 20 (3), 2022 | | 2022 |
| Mepolizumab-Related Adverse Events in Severe Eosinophilic Asthma: A Real-Life Study. S NAZİK BAHÇECİOĞLU, M TÜRK, E ATAYIK, G PAÇACI ÇETİN, ... Asthma Allergy Immunology/Astim Allerji Immunoloji 20 (2), 2022 | | 2022 |
| Bronkoprovokasyon Testlerinin Klinik Kullanımı GP ÇETİN, İ YILMAZ Turkiye Klinikleri Pulmonary Medicine-Special Topics 15 (1), 28-34, 2022 | | 2022 |
Insu YılmazErciyes University School of Medicine Department of Chest Diseases, Division of Allergy and Clinical在 erciyes.edu.tr 的电子邮件经过验证
